Post Operative Atrial Fibrillation Post Cardiac Surgery ( CABG and VALVE REPLACEMENT )

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This study aims to assess the percent and risk factors of postoperative atrial fibrillation in patients undergoing cardiac surgery in Assiut university heart hospital

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

≥18 years scheduled for first-time planned cardiac surgery ( CABG and Valve replacement)

Patients who are in sinus rhythm and not taking any antiarrhythmic medication, other than beta-adrenergic blocking agents, at the time of surgery.

Willingness to participate and provision of informed consent

Disqualifiers

Prior history of cardiac surgery.

Pediatric population less than 18 years.

Patients with history of hyperthyroidism

Patients with electrolyte disturbance

Trial population

1. ≥18 years scheduled for first-time planned cardiac surgery ( CABG and Valve replacement) 2. Patients who are in sinus rhythm and not taking any antiarrhythmic medication, other than beta-adrenergic blocking agents, at the time of surgery. 3. Willingness to participate and provision of informed consent

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

112 Participants
are grouped into 2 trial groups
Group A: First group is patients who developed post operative atrial fibrillation
Group B: Second group is patients who don't develop post operative atrial fibrillation

Trial outcomes

Primary outcomes

1

Post operative atrial fibrillation

Prevelance of post operative atrial fibrillation in patients undergoing cardiac surgery ( past CABG and valve replacement )

Time frame
One year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: